A wedge resection is the term for surgically removing a small piece of cancerous lung tissue along with a margin of healthy tissue around it. It's one type of sublobar resection, which means less than a full lobe comes out. The operation suits small, peripheral tumors, patients with limited lung reserve, and some diagnostic cases where tissue confirmation comes first. What follows covers how it differs from segmentectomy and lobectomy, what the margin actually means in millimeters, and where the approach runs into trouble.

Wedge Resection Defined in One Sentence

Picture a surgeon taking a triangular slice out of a lung, wider at the outer edge and tapering inward, so the cancer sits in the middle with clean tissue on every side. That shape is where the name comes from. The specimen usually spans 2 to 5 centimeters of lung tissue, depending on tumor size and how much clearance the surgeon wants.

The word "wedge" describes geometry, not a fixed size. A surgeon performing a wedge resection on a 1.2-centimeter nodule near the pleural surface might remove a specimen under 3 centimeters across; the same operation on a 2.5-centimeter lesion deeper in the parenchyma removes more. Nothing about the term guarantees a specific volume.

Sublobar surgery splits into two named operations, and the distinction matters for staging and survival data. A wedge resection cuts across lung tissue without regard to the segmental anatomy, while a segmentectomy follows the bronchovascular boundaries of a bronchopulmonary segment. Both preserve more lung than a lobectomy, which removes an entire lobe — roughly 20 percent of lung volume on the right side, less on the left.

The term you'll see in operative notes is usually "wedge resection" or "nonanatomical resection." Pathology reports may label the specimen "lung wedge" with dimensions and margin distance in millimeters. If a report says "sublobar resection, favor wedge," the pathologist is inferring the technique from specimen shape rather than reading it off the surgical note.

How a Wedge Resection Differs From Segmentectomy and Lobectomy

These three operations form a ladder of increasing tissue removal, and picking the right rung decides how much breathing capacity a patient keeps. A wedge takes the smallest piece, a segmentectomy takes a defined anatomical unit, and a lobectomy takes a full lobe plus its lymph node stations. The trade-off runs the same direction throughout: less tissue removed means more lung preserved and a higher chance of a close or positive margin.

Feature Wedge resection Segmentectomy Lobectomy
Tissue removed Nonanatomical slice, often 2–5 cm specimen One bronchopulmonary segment Entire lobe
Typical tumor size ceiling Under 2 cm, peripheral Up to 2 cm, peripheral Any size, central or peripheral
Margin risk Highest — cuts across parenchyma Intermediate — follows anatomical plane Lowest for the lobe itself
Lymph node sampling Often omitted or limited Usually segmental nodes Hilar and mediastinal dissection
Lung volume lost Smallest Moderate Largest, roughly 20% of right lung
Standard use Compromised reserve, diagnosis, metastasis Small peripheral tumors with adequate reserve Standard of care for fit patients

The numbers on this table come from criteria used in the landmark JCOG0802 and CALGB 140503 trials, which compared sublobar resection against lobectomy for small peripheral tumors. Both enrolled tumors of 2 centimeters or less. JCOG0802 reported in 2022 that segmentectomy produced overall survival at least as good as lobectomy in that population, a result that reshaped practice for small peripheral lesions.

Segmentectomy beat lobectomy on that endpoint in JCOG0802, but wedge resection has never carried the same evidence weight for primary lung cancer. CALGB 140503, published in 2023, found that sublobar resection overall was non-inferior to lobectomy for disease-free survival in tumors of 2 centimeters or less, yet the trial's sublobar arm mixed wedge and segmentectomy cases. That mix is exactly why surgeons argue about which sublobar operation the data actually supports.

Use the ladder this way: fit patient with a 3-centimeter tumor gets a lobectomy; marginal reserve with a 1.5-centimeter peripheral tumor gets a segmentectomy if anatomy allows; a patient who couldn't tolerate a segmentectomy, or a nodule being removed mainly to establish a diagnosis, gets a wedge. The deciding variable is physiological reserve measured by predicted postoperative lung function, not tumor size alone.

What "Margin of Healthy Tissue" Actually Means in Millimeters

A margin is the distance from the cancer's edge to the nearest cut surface of the specimen, and pathologists report it in millimeters on the final report. For lobectomy, a 2-millimeter margin is generally accepted; for wedge resection, the threshold shifts because the specimen is smaller and the cut runs closer to the tumor. Many thoracic surgery groups aim for a margin at least equal to the tumor's own diameter, which for a 1.5-centimeter nodule means 15 millimeters of clearance.

That rule explains why wedge resection fails more often on larger tumors. A 2-centimeter tumor sitting 5 millimeters from the pleural surface leaves barely any room to cut a margin on one side, and the specimen comes out with a margin the pathologist calls "close" at 3 millimeters. Close margins drive reoperation or adjuvant discussions, and they show up in the literature as the leading cause of local recurrence after sublobar surgery.

Frozen section analysis happens in the operating room, where a pathologist examines the cut edge while the patient is still on the table. If the frozen section shows cancer at the inked margin, the surgeon can extend the resection — converting a wedge into a segmentectomy or lobectomy — or stop and accept the risk. Not every hospital has a pathologist available for intraoperative frozen section on lung specimens, and that staffing gap changes how aggressively a surgeon can push a wedge.

Margin distance also depends on how the specimen is handled after removal. A lung deflates once it leaves the chest, and an inflated specimen measures larger than a deflated one. Surgeons sometimes inflate the lung with air before stapling to preserve margin geometry, a maneuver described in thoracic technique literature. Ask your surgeon whether the specimen is measured inflated or deflated if margin numbers matter to your case.

When Surgeons Choose a Wedge Resection Over a Bigger Operation

The clearest case is a patient whose breathing tests rule out a lobectomy. A predicted postoperative FEV1 below roughly 30 percent of predicted, or a predicted postoperative DLCO below 30 percent, tips the risk-benefit calculation toward the smallest possible resection. Those thresholds appear in guidelines from the American College of Chest Physicians and the European Society of Thoracic Surgeons, and they're functional cutoffs rather than tumor cutoffs.

A second case is the diagnostic wedge, where imaging can't confirm what a nodule is. A patient with a 1.8-centimeter ground-glass opacity and no tissue diagnosis may go to the operating room for a wedge that serves as both biopsy and, if cancer is confirmed, definitive treatment in one anesthetic. This single-procedure approach avoids a separate needle biopsy, which carries its own pneumothorax risk of roughly 15 to 25 percent in published series depending on needle size and patient factors.

Metastasectomy is the third common indication. When colorectal cancer or sarcoma spreads to the lung as one or two peripheral nodules, wedge resection removes them without sacrificing a lobe. The same operation can be repeated years later on the other side if new nodules appear, which is why preserving lung volume matters in this group — these patients often face more than one thoracic operation in their lifetime.

Anatomy can force the choice regardless of intent. A nodule sitting in the periphery of the right upper lobe, reachable by a stapler across a thin rim of parenchyma, may simply not be amenable to segmentectomy because the segmental bronchus and artery are hard to isolate. When the anatomy is unfavorable, the surgeon's realistic option is a wedge or a lobectomy, and in a high-risk patient the wedge wins. Ask specifically whether your anatomy permits segmentectomy before accepting a plan built around wedge resection.

The Operation Itself: Steps From Incision to Specimen

Wedge resection is usually done by video-assisted thoracoscopic surgery, known as VATS, or by robot-assisted thoracoscopic surgery. Both approaches use small ports rather than a large incision, and both follow the same sequence inside the chest. Expect the operation to run roughly 60 to 120 minutes for a straightforward wedge, with longer times when adhesions or conversions arise.

1: General anesthesia with a double-lumen endotracheal tube, allowing the operated lung to deflate while the other lung ventilates. 2: Patient positioned in lateral decubitus, with the operated side up and the table flexed to open the rib spaces. 3: Ports placed, typically two or three, with a utility incision for specimen extraction. 4: Camera advanced to locate the nodule using preoperative marking — a hook wire, dye, or radiotracer placed by radiology when the lesion is small or deep. 5: Stapler fired across the lung tissue to divide it, with the cancer centered in the specimen and as much clearance as anatomy permits. 6: Specimen retrieved in a bag, oriented by the surgeon, and sent for frozen section if the team wants intraoperative margin confirmation. 7: Air leak check, a chest tube left in place, and closure of the port sites.

Conversion to open thoracotomy happens in a minority of cases and is not a failure — it's a judgment call when bleeding, dense adhesions, or an inability to locate the nodule makes the minimally invasive approach unsafe. Rates vary widely by center and case complexity, so ask your surgeon for their own conversion rate rather than relying on a general figure.

Failure handling matters more than most patients realize. If frozen section comes back positive at the margin, the team either extends the resection or accepts the close margin and plans surveillance or adjuvant treatment. If a small nodule can't be found at all, the surgeon may palpate the lung with instruments, use intraoperative ultrasound, or convert to open surgery where direct palpation is easier. Every one of those paths gets decided in the room, not beforehand.

Recovery Timeline and the Air Leak Problem

Most wedge resection patients leave the hospital in 2 to 4 days, faster than lobectomy patients in comparable series. The chest tube typically comes out when the air leak stops and drainage falls below a set volume, often 200 to 300 milliliters per day depending on surgeon preference. Pain control shifts from epidural or paravertebral block to oral analgesics within the first two days.

Prolonged air leak is the most common complication, defined as a leak lasting more than 5 days. It's common enough that the Society of Thoracic Surgeons general thoracic database tracks it as a quality metric. A leak that persists past a week may need pleurodesis, a blood patch, or in stubborn cases a return to the operating room, and it's the main reason a short operation turns into a longer stay.

Breathing exercises start the day of surgery, and the incentive spirometer earns its reputation here. Patients who don't inflate the remaining lung fully risk atelectasis, which can mimic pneumonia on imaging and delay discharge. Walking within the first 24 hours reduces that risk and is standard on enhanced recovery protocols used by most thoracic surgery units.

Return to normal activity varies with the patient's baseline. Desk work often resumes in 2 to 4 weeks; heavy lifting waits 6 weeks or more. Lung function after a wedge drops less than after lobectomy, but there's no reliable percentage to promise — the drop depends on how much functional tissue was removed and what remained. Ask your surgeon to compare pre- and postoperative pulmonary function tests at your follow-up rather than estimating from someone else's numbers.

Where the Term Gets Confused: Biopsy, Segmentectomy, and Lobectomy

The most frequent mix-up is calling a wedge resection a "lung biopsy." A biopsy is any tissue sampling procedure, including needle biopsy through the chest wall and bronchoscopic sampling through the airway. A wedge resection is a surgical biopsy when it's done primarily for diagnosis, but it's also a definitive cancer operation when margins are clear — the same procedure serves two roles.

Segmentectomy gets confused with wedge because both are sublobar. The anatomical distinction is worth knowing for your own records: a segmentectomy has a named segment, such as the superior segment of the left lower lobe, and the pathology report will specify it. A wedge report describes dimensions and margin distance without naming a segment.

Another misuse is treating "wedge resection" as automatically curative for early-stage lung cancer. It isn't wrong to use it that way, but it's incomplete: cure depends on margin status, tumor size, nodal staging, and histology, not on the operation's name. A wedge with a clear margin on a 1-centimeter tumor and negative nodes behaves very differently from a wedge with a 1-millimeter margin on a 2.4-centimeter tumor.

One more confusion worth correcting: the term "limited resection" is sometimes used as a synonym for wedge resection, but in some guidelines it covers both wedge and segmentectomy. If a study reports outcomes for "limited resection," check the methods section. CALGB 140503's sublobar arm included both operations, which limits how confidently its results apply to wedge alone.

Staging and Pathology Findings That Change the Plan

Wedge resection often produces less nodal information than lobectomy, and that gap can understage a patient. A lobectomy typically includes sampling or dissection of hilar and mediastinal lymph nodes; a wedge for a presumed early tumor may include only limited sampling or none. Without adequate nodal staging, a patient with occult mediastinal disease may be treated as stage I when the true stage is III.

Guidelines from the National Comprehensive Cancer Network recommend pathological nodal staging for any patient being treated with curative intent for non-small cell lung cancer. That recommendation creates tension with the wedge's role in fragile patients, where extensive nodal dissection adds operative time and risk. The compromise in practice is often systematic sampling of a few stations rather than full dissection.

Pathology details also steer what comes next. Visceral pleural invasion, lymphovascular invasion, and a micropapillary or solid predominant pattern all raise recurrence risk even in a small resected tumor. When those features appear on a wedge specimen, the multidisciplinary team may recommend completing the resection to a lobectomy plus nodal dissection, or adjuvant therapy if the patient can't tolerate more surgery.

Molecular testing on the specimen guides treatment in advanced or recurrent disease. A wedge specimen that confirms adenocarcinoma typically gets tested for EGFR mutations, ALK rearrangements, and PD-L1 expression, since those results open targeted therapy or immunotherapy options if cancer returns. Tissue volume matters here — small wedge specimens can be exhausted by testing, so ask whether the lab has enough tissue for both diagnosis and molecular panels.

Outcomes, Recurrence, and the Evidence Gap

Local recurrence after wedge resection runs higher than after lobectomy in most comparative series, and the gap is attributed largely to margin status and inadequate nodal staging rather than to the operation's size alone. The JCOG0802 and CALGB 140503 trials were designed around sublobar resection for tumors of 2 centimeters or less, and neither trial settles the wedge-versus-segmentectomy question directly, because wedge was not the sole sublobar operation in either.

A patient-facing way to read the evidence: for small peripheral tumors in patients who can tolerate it, segmentectomy has trial support for survival at least comparable to lobectomy. Wedge resection has the weakest oncologic evidence among the three operations, but the strongest case for preserving lung function and shortening recovery. Those two facts can coexist, and they're why the choice is genuinely individualized.

Cost differences exist but vary too much by country, insurer, and hospital to quote reliably here. In general terms, a shorter operation, shorter stay, and fewer ICU days make wedge resection the cheaper operation in most systems, while a recurrence requiring further treatment can erase that advantage. Ask your hospital's billing office for its own estimate rather than relying on a general figure.

The realistic surveillance plan after wedge resection is imaging at regular intervals, typically a CT scan every 6 to 12 months for the first few years, with the schedule set by the treating team based on stage and histology. Skipping follow-up because the operation was "small" is a mistake — the smaller margin and lighter nodal staging are precisely why surveillance matters more, not less.

FAQ

Is wedge resection the same as a limited resection?

No, though the terms overlap in casual use. "Limited resection" or "sublobar resection" covers both wedge resection and segmentectomy, and some guidelines and trials use it that way. When you read a study reporting limited resection outcomes, check whether wedge and segmentectomy cases were pooled, because their recurrence profiles differ.

What is the minimum margin for a wedge resection?

There's no single universal number, but many thoracic surgery groups aim for a margin at least as wide as the tumor's diameter, so a 1.5-centimeter nodule calls for roughly 15 millimeters of clearance. Pathology reports state the actual distance in millimeters, and a margin under 5 millimeters is commonly flagged as close and triggers a discussion about further surgery or adjuvant treatment.

Can a wedge resection be done if the nodule is deep in the lung?

It's difficult and often not the first choice. Deep nodules are hard to locate thoracoscopically and hard to remove with an adequate margin using a stapler that cuts across parenchyma. Surgeons may mark the nodule preoperatively with a hook wire or dye, use intraoperative ultrasound, or convert to a segmentectomy or lobectomy when the lesion sits too far from the pleural surface.

Does a wedge resection remove lymph nodes?

Often only limited sampling, and sometimes none. That's the main oncologic weakness of the operation compared with lobectomy, which typically includes hilar and mediastinal nodal dissection. The National Comprehensive Cancer Network recommends pathological nodal staging for curative-intent lung cancer treatment, so ask your surgeon what nodal sampling the plan includes.

How long is the hospital stay after a wedge resection?

Typically 2 to 4 days, shorter than after a lobectomy in comparable series. The chest tube comes out when the air leak stops and drainage falls below a set threshold, often 200 to 300 milliliters per day. A prolonged air leak lasting more than 5 days is the most common reason a stay runs longer than expected.

Is wedge resection curative for early-stage lung cancer?

It can be, when the tumor is small, peripheral, the margin is clear, and nodal staging is adequate. It's less reliably curative than lobectomy or segmentectomy when margins are close or nodes weren't sampled. The operation's name doesn't determine cure — margin distance, tumor size, nodal status, and histologic features do.

What's the difference between a wedge resection and a needle biopsy?

A needle biopsy samples tissue through the chest wall with imaging guidance and is purely diagnostic. A wedge resection is a surgical operation that removes the nodule plus surrounding lung, and it can be diagnostic, therapeutic, or both in a single anesthetic. Needle biopsy carries a pneumothorax risk reported at roughly 15 to 25 percent in published series; wedge resection carries surgical and anesthesia risks instead.

Can a wedge resection be repeated on the same lung?

Yes, and that's one reason it's favored for metastatic disease. Removing small peripheral nodules repeatedly preserves more lung volume than lobectomy would across multiple operations. Scarring and adhesions from the first procedure make later operations technically harder, so the surgeon's experience with reoperative thoracic surgery matters.

This article is general educational information about a surgical term and does not constitute a diagnosis, treatment plan, or medical advice. Outcomes depend on individual pathology, staging, and lung function, and no article can predict them for a specific patient. Consult a qualified thoracic surgeon or oncologist in your jurisdiction before making treatment decisions; if you are in immediate danger or crisis, contact local emergency services.